Menstruation News and Research

RSS

Menstruation is the shedding of the uterine lining (endometrium). It occurs on a regular basis in reproductive-age females of certain mammal species.

Study shows estrogen stabilization may protect women from brain aneurysms risk

Results from a retrospective, case-control study presented today at the Society of NeuroInterventional Surgery (SNIS) 7th Annual Meeting could have significant implications for women at risk of brain aneurysms as data shows that oral contraceptives (OC) and hormone replacement therapy (HRT) may yield the additional benefit of protecting against the formation and/or rupture of brain aneurysms – balloon-like sacks that form in a weakened artery wall and, upon bursting, can cause severe disability or death.

31 Jul 2010

Investment report on BioElectronics

MicroStockProfit.com announces an investment report featuring BioElectronics Corp. The report includes financial, comparative and investment analyses, and recent company news that you need to know to make an educated investment decision.

1 Jul 2010

Ferring announces availability of LYSTEDA for cyclic heavy menstrual bleeding in U.S.

Ferring Pharmaceuticals Inc. announced today the U.S. commercial availability of LYSTEDA™ (tranexamic acid) tablets, the only non-hormonal and non-surgical therapy indicated specifically for the treatment of women with cyclic heavy menstrual bleeding (HMB). In clinical studies, LYSTEDA significantly reduced menstrual blood loss (MBL) over three and six cycles of use with the reduction seen as early as the first cycle of use.

21 Jun 2010

Abbott, Neurocrine enter collaboration to develop, commercialize elagolix for endometriosis-related pain

Abbott and Neurocrine Biosciences, Inc. today announced that they have entered into a collaboration agreement to develop and commercialize elagolix for the treatment of endometriosis-related pain. Elagolix is a novel, first-in-class oral gonadotropin-releasing hormone (GnRH) antagonist, which has recently completed a phase IIb study in endometriosis. In addition to endometriosis, elagolix will be evaluated for the treatment of uterine fibroids.

16 Jun 2010

Natazia tablets receive FDA approval for prevention of pregnancy

Bayer HealthCare Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has approved Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for the prevention of pregnancy.

7 May 2010

SE5-OH with Natural S-equol supplement appears to be safe for pre- and post-menopausal women

Healthy pre-and post-menopausal Japanese women who took a supplement of SE5-OH containing Natural S-equol, a novel soy germ-based ingredient under development for the management of menopausal symptoms, had measures of reproductive hormones that stayed within normal limits throughout the study.

3 Apr 2010

Rates of breast cancer occurrences in Asian women rising among specific ethnic groups

Research scientists from the Cancer Prevention Institute of California (CPIC) released the results of a study of breast cancer in Asian women which examined their cancer rates by ethnicity, age and immigrant status. The findings challenge the notion that breast cancer rates are uniformly low across the population of Asian women and indicate rising rates of occurrences in specific ethnic groups. CPIC scientists studied Asian populations in California, the state with the largest and most diverse Asian population in the U.S.

19 Mar 2010

Kisspeptin injections may help restore women's fertility

Twice weekly injections of the hormone kisspeptin may provide a new treatment to restore fertility in some women. The research is being presented at the Society for Endocrinology BES meeting in Manchester.

16 Mar 2010

New guidance produced to help GPs identify symptoms of cervical cancer in young women

New guidance has been produced to help GPs identify symptoms of cervical cancer and facilitate early diagnosis of the disease in young women.

6 Mar 2010

Dermatologist speaks about common forms of hair loss and treatment options at 68th Annual Meeting

For many women, unexplained hair loss can take a significant psychological toll on their overall quality of life. From altering their hairstyle to hide a thinning part to scaling back their hair care regimen in an effort to halt further hair loss, women try countless ways to cover up this problem - and the results are often lukewarm at best.

4 Mar 2010

AAN guideline evaluates drugs’ safety and efficacy for treatment of muscle cramps

A new guideline from the American Academy of Neurology recommends that the drug quinine, although effective, should be avoided for treatment of routine muscle cramps due to uncommon but serious side effects.

23 Feb 2010

Pivotal Research to study investigational drug for menstrual cramps

A leading clinical research center in Peoria has joined an international research program to study an investigational drug designed as a possible treatment for painful menstrual cramps, or dysmenorrhea, a condition that affects between 45 and 90 percent of women of childbearing age in the United States.

10 Feb 2010

Butter leads to lower blood fat levels compared to olive oil

High blood fat levels normally raise the cholesterol values in the blood, which in turn elevates the risk of atherosclerosis and heart attack. Now a new study from Lund University in Sweden shows that butter leads to considerably less elevation of blood fats after a meal compared with olive oil and a new type of canola and flaxseed oil.

9 Feb 2010

New study to investigate preventative programmes for anaemia control in young women

A new study led by LSTM will investigate whether long-term weekly iron and folic acid supplementation can reduce anaemia without increasing the risk of contracting malaria.

3 Feb 2010

Study: Fat tissue in women with PCOS produces inadequate amount of hormone

Fat tissue in women with Polycystic Ovary Syndrome produces an inadequate amount of the hormone that regulates how fats and glucose are processed, promoting increased insulin resistance and inflammation, glucose intolerance, and greater risk of diabetes and heart disease, according to a study conducted at the Center for Androgen-Related Research and Discovery at Cedars-Sinai Medical Center.

3 Feb 2010

Fat tissue in PCOS patients may predispose them to diabetes and heart disease

3 Feb 2010

New iPhone application allows women to track vital health details

Flatcracker Software announced the release of Lady Biz 3.0, a specially designed iPhone application that enables women to record and track vital daily health details including menstruation details, sleep patterns, waking temperature, weight, and more.

19 Jan 2010

New issue from Annals of Internal Medicine

Prescriptions of some opioids, such as oxycodone, have increased significantly over the past decade. As long-term opioid therapy for chronic noncancer pain becomes more common, the deaths associated with opioids increase.

19 Jan 2010

Androgen replacement therapy may ward off heart damage, says study

A man's male hormones may ward off heart damage by helping vessels around the heart regenerate, suggest Australian researchers in a report posted January 13 in the Journal of Experimental Medicine (www.jem.org).

18 Jan 2010

Salt Lake City research center joins international drug trial program for painful menstrual cramps

A leading clinical research center in Salt Lake City has joined an international trial program to test an experimental new drug designed to treat painful menstrual cramps, or dysmenorrhea, a condition that affects between 45 and 90 percent of women of childbearing age in the United States. Although not life threatening, dysmenorrhea can be debilitating and psychologically taxing and is one of the leading causes of absenteeism from work and school.

12 Jan 2010

Menstruation News and Research

Further Reading

Study shows estrogen stabilization may protect women from brain aneurysms risk

Investment report on BioElectronics

Ferring announces availability of LYSTEDA for cyclic heavy menstrual bleeding in U.S.

Abbott, Neurocrine enter collaboration to develop, commercialize elagolix for endometriosis-related pain

Natazia tablets receive FDA approval for prevention of pregnancy

SE5-OH with Natural S-equol supplement appears to be safe for pre- and post-menopausal women

Rates of breast cancer occurrences in Asian women rising among specific ethnic groups

Kisspeptin injections may help restore women's fertility

New guidance produced to help GPs identify symptoms of cervical cancer in young women

Dermatologist speaks about common forms of hair loss and treatment options at 68th Annual Meeting

AAN guideline evaluates drugs’ safety and efficacy for treatment of muscle cramps

Pivotal Research to study investigational drug for menstrual cramps

Butter leads to lower blood fat levels compared to olive oil

New study to investigate preventative programmes for anaemia control in young women

Study: Fat tissue in women with PCOS produces inadequate amount of hormone

Fat tissue in PCOS patients may predispose them to diabetes and heart disease

New iPhone application allows women to track vital health details

New issue from Annals of Internal Medicine

Androgen replacement therapy may ward off heart damage, says study

Salt Lake City research center joins international drug trial program for painful menstrual cramps

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Discover how SciY empowers scientists

Latest News